Anya Biopharm Inc. (TPEX:7776)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.80
+0.80 (2.67%)
At close: Apr 28, 2026
9.61%
Market Cap 1.51B
Revenue (ttm) 16.27M
Net Income (ttm) -64.02M
Shares Out 49.10M
EPS (ttm) -1.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 42,678
Average Volume 77,596
Open 30.80
Previous Close 30.00
Day's Range 29.90 - 31.40
52-Week Range 25.65 - 70.60
Beta n/a
RSI 50.82
Earnings Date May 4, 2026

About Anya Biopharm

Anya Biopharm Inc., a pharmaceutical company, research and development of new biotech drugs, focusing on oral peptides and converting injectable drugs into oral formulations in Taiwan, the rest of Asia, and Europe. The company is also developing ANY002 and ANY004, oral GLP1 products; ANY003, a tnfα inhibitor; and ANY005. In addition, it engages in the research, development, and testing business. Anya Biopharm Inc. was founded in 2016 and is based in Taipei, Taiwan. [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 7776
Full Company Profile

Financial Performance

In 2025, Anya Biopharm's revenue was 16.27 million, a decrease of -24.66% compared to the previous year's 21.60 million. Losses were -64.02 million, 73.2% more than in 2024.

Financial Statements

News

There is no news available yet.